Overview
Gary Sherrill is a Hematologist Oncology specialist and an Oncologist in Greensboro, North Carolina. Dr. Sherrill is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Familial Pancreatic Cancer. Dr. Sherrill is currently accepting new patients.
His clinical research consists of co-authoring 4 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3518 Drawbridge Pkwy, Suite 210, Greensboro, NC 27410
1200 N Elm St, Greensboro, NC 27401
501 N Elam Ave, Greensboro, NC 27403
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
The Moses H Cone Memorial Hospital Operating Corporation
Mohamed Mohamed is a Hematologist and an Oncologist in Greensboro, North Carolina. Dr. Mohamed is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and EGFR Positive Lung Cancer. Dr. Mohamed is currently accepting new patients.
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Wake Forest University Health Sciences
William Petty is a Hematologist Oncology specialist and a Hematologist in Statesville, North Carolina. Dr. Petty is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. His top areas of expertise are Thymic Epithelial Tumor, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Advanced Bronchoscopy, and Bone Marrow Aspiration. Dr. Petty is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Autoimmune Hemolytic AnemiaDr. Sherrill isDistinguished. Learn about Autoimmune Hemolytic Anemia.
- Colorectal CancerDr. Sherrill isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Sherrill isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Sherrill isDistinguished. Learn about Familial Pancreatic Cancer.
- Gallbladder AdenocarcinomaDr. Sherrill isDistinguished. Learn about Gallbladder Adenocarcinoma.
- HemochromatosisDr. Sherrill isDistinguished. Learn about Hemochromatosis.
- Advanced
- Adult Immune ThrombocytopeniaDr. Sherrill isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Anal CancerDr. Sherrill isAdvanced. Learn about Anal Cancer.
- AngiosarcomaDr. Sherrill isAdvanced. Learn about Angiosarcoma.
- Gallbladder CancerDr. Sherrill isAdvanced. Learn about Gallbladder Cancer.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Gastroesophageal Junction CancerDr. Sherrill isAdvanced. Learn about Gastroesophageal Junction Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Sherrill isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Sherrill isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Sherrill isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Ampullary CancerDr. Sherrill isExperienced. Learn about Ampullary Cancer.
- AnemiaDr. Sherrill isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell LymphomaDr. Sherrill isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
